A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium

Biomaterials

Volumn 34, Issue 29, 2013, Pages 7158-7167

  Koirala, Adarsha ^a   Conley, Shannon M ^a   Naash, Muna I ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

DNA nanoparticle; Non viral gene therapy; Retinal pigment epithelium; RPE65

Indexed keywords

ADENO-ASSOCIATED VIRUS; CLINICAL APPLICATION; DNA NANOPARTICLES; NONVIRAL GENE THERAPY; POLYETHYLENE IMINES; RETINAL PIGMENT EPITHELIUM; RPE65; TRANSFECTION EFFICIENCY;

GENE EXPRESSION; LIPOSOMES; MEDICAL APPLICATIONS; VIRUSES;

GENE THERAPY;

ADENOVIRUS VECTOR; CHITOSAN; LIPOSOME; MINICIRCLE DNA; NANOPARTICLE; ORGANIC POLYMER; PLASMID DNA; POLYLYSINE; POLYMER; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; DNA SEQUENCE; DNA VECTOR; GENE EXPRESSION; GENE SILENCING; INSULATOR ELEMENT; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE THERAPY; PATIENT SAFETY; PHAGOCYTOSIS; PLASMID; PRIORITY JOURNAL; RETINA PIGMENT EPITHELIOPATHY; REVIEW;

ANIMALS; DNA; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; NANOTECHNOLOGY; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM;

ADENO-ASSOCIATED VIRUS;

EID: 84879606470     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.002     Document Type: Review

References (152)

1. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005, 85:845-881.
2. Ishida K., Panjwani N., Cao Z., Streilein J.W. Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul Immunol Inflamm 2003, 11:91-105.
3. Van Hooser J.P., Liang Y., Maeda T., Kuksa V., Jang G.F., He Y.G., et al. Recovery of visual functions in a mouse model of Leber congenital amaurosis. JBiol Chem 2002, 277:19173-19182.
4. Batten M.L., Imanishi Y., Tu D.C., Doan T., Zhu L., Pang J., et al. Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis. PLoS Med 2005, 2:e333.
5. Zhang T., Baehr W., Fu Y. Chemical Chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis. Invest Ophthalmol Vis Sci 2012, 53:3349-3356.
6. Eiraku M., Takata N., Ishibashi H., Kawada M., Sakakura E., Okuda S., et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 2011, 472:51-56.
7. Nakano T., Ando S., Takata N., Kawada M., Muguruma K., Sekiguchi K., et al. Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012, 10:771-785.
8. West E.L., Gonzalez-Cordero A., Hippert C., Osakada F., Martinez-Barbera J.P., Pearson R.A., et al. Defining the integration capacity of embryonic stem cell-derived photoreceptor precursors. Stem Cells 2012, 30:1424-1435.
9. MacLaren R.E., Pearson R.A., MacNeil A., Douglas R.H., Salt T.E., Akimoto M., et al. Retinal repair by transplantation of photoreceptor precursors. Nature 2006, 444:203-207.
10. Warfvinge K., Kiilgaard J.F., Lavik E.B., Scherfig E., Langer R., Klassen H.J., et al. Retinal progenitor cell xenografts to the pig retina: morphologic integration and cytochemical differentiation. Arch Ophthalmol 2005, 123:1385-1393.
11. Falkner-Radler C.I., Krebs I., Glittenberg C., Povazay B., Drexler W., Graf A., et al. Human retinal pigment epithelium (RPE) transplantation: outcome after autologous RPE-choroid sheet and RPE cell-suspension in a randomised clinical study. Br J Ophthalmol 2011, 95:370-375.
12. Bennicelli J., Wright J.F., Komaromy A., Jacobs J.B., Hauck B., Zelenaia O., et al. Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer. Mol Ther 2008, 16:458-465.
13. Le Meur G., Stieger K., Smith A.J., Weber M., Deschamps J.Y., Nivard D., et al. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther 2007, 14:292-303.
14. Li Q., Miller R., Han P.Y., Pang J., Dinculescu A., Chiodo V., et al. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol Vis 2008, 14:1760-1769.
15. Jacobson S.G., Cideciyan A.V., Ratnakaram R., Heon E., Schwartz S.B., Roman A.J., et al. Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years. Arch Ophthalmol 2012, 130:9-24.
16. Hufnagel R.B., Ahmed Z.M., Correa Z.M., Sisk R.A. Gene therapy for Leber congenital amaurosis: advances and future directions. Graefes Arch Clin Exp Ophthalmol 2012, 250:1117-1128.
17. Wu Z., Yang H., Colosi P. Effect of genome size on AAV vector packaging. Mol Ther 2010, 18:80-86.
18. den Hollander A.I., Roepman R., Koenekoop R.K., Cremers F.P. Leber congenital amaurosis: genes, proteins and disease mechanisms. Prog Retin Eye Res 2008, 27:391-419.
19. Allikmets R. Aphotoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997, 17:122.
20. Liu X., Bulgakov O.V., Darrow K.N., Pawlyk B., Adamian M., Liberman M.C., et al. Usherin is required for maintenance of retinal photoreceptors and normal development of cochlear hair cells. Proc Natl Acad Sci U S A 2007, 104:4413-4418.
21. Duan D., Li Q., Kao A.W., Yue Y., Pessin J.E., Engelhardt J.F. Dynamin is required for recombinant adeno-associated virus type 2 infection. JVirol 1999, 73:10371-10376.
22. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 1987, 84:7413-7417.
23. Torchilin V.P., Rammohan R., Weissig V., Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A 2001, 98:8786-8791.
24. Ahmad I., Longenecker M., Samuel J., Allen T.M. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 1993, 53:1484-1488.
25. Schwendener R.A., Schott H. Liposome formulations of hydrophobic drugs. Methods Mol Biol 2010, 605:129-138.
26. Xu Y., Szoka F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry (Mosc) 1996, 35:5616-5623.
27. Lechardeur D., Sohn K.J., Haardt M., Joshi P.B., Monck M., Graham R.W., et al. Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther 1999, 6:482-497.
28. Xing X., Zhang S., Chang J.Y., Tucker S.D., Chen H., Huang L., et al. Safety study and characterization of E1A-liposome complex gene-delivery protocol in an ovarian cancer model. Gene Ther 1998, 5:1538-1544.
29. Stopeck A.T., Hersh E.M., Akporiaye E.T., Harris D.T., Grogan T., Unger E., et al. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. JClin Oncol 1997, 15:341-349.
30. Ishikado A., Uesaki S., Suido H., Nomura Y., Sumikawa K., Maeda M., et al. Human trial of liposomal lactoferrin supplementation for periodontal disease. Biol Pharm Bull 2010, 33:1758-1762.
31. Stathopoulos G.P., Antoniou D., Dimitroulis J., Stathopoulos J., Marosis K., Michalopoulou P. Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer. Cancer Chemother Pharmacol 2011, 68:945-950.
32. Liu H.A., Liu Y.L., Ma Z.Z., Wang J.C., Zhang Q. Alipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model. Invest Ophthalmol Vis Sci 2011, 52:4789-4794.
33. Shafaa M.W., El Shazly L.H., El Shazly A.H., El gohary A.A., El hossary G.G. Efficacy of topically applied liposome-bound tetracycline in the treatment of dry eye model. Vet Ophthalmol 2011, 14:18-25.
34. Dalkara D., Kolstad K.D., Caporale N., Visel M., Klimczak R.R., Schaffer D.V., et al. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther 2009, 17:2096-2102.
35. Hangai M., Kaneda Y., Tanihara H., Honda Y. Invivo gene transfer into the retina mediated by a novel liposome system. Invest Ophthalmol Vis Sci 1996, 37:2678-2685.
36. Masuda I., Matsuo T., Yasuda T., Matsuo N. Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 1996, 37:1914-1920.
37. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. Aversatile vector for gene and oligonucleotide transfer into cells in culture and invivo: polyethylenimine. Proc Natl Acad Sci U S A 1995, 92:7297-7301.
38. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., et al. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997, 4:409-418.
39. Boletta A., Benigni A., Lutz J., Remuzzi G., Soria M.R., Monaco L. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther 1997, 8:1243-1251.
40. Brunot C., Ponsonnet L., Lagneau C., Farge P., Picart C., Grosgogeat B. Cytotoxicity of polyethyleneimine (PEI), precursor base layer of polyelectrolyte multilayer films. Biomaterials 2007, 28:632-640.
41. Hashemi M., Parhiz B.H., Hatefi A., Ramezani M. Modified polyethyleneimine with histidine-lysine short peptides as gene carrier. Cancer Gene Ther 2011, 18:12-19.
42. Gomes dos Santos A.L., Bochot A., Tsapis N., Artzner F., Bejjani R.A., Thillaye-Goldenberg B., et al. Oligonucleotide-polyethylenimine complexes targeting retinal cells: structural analysis and application to anti-TGFbeta-2 therapy. Pharm Res 2006, 23:770-781.
43. Fattal E., De Rosa G., Bochot A. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids. Int J Pharm 2004, 277:25-30.
44. Pitkanen L., Ruponen M., Nieminen J., Urtti A. Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers. Pharm Res 2003, 20:576-583.
45. Peeters L., Sanders N.N., Braeckmans K., Boussery K., Van de Voorde J., De Smedt S.C., et al. Vitreous: a barrier to nonviral ocular gene therapy. Invest Ophthalmol Vis Sci 2005, 46:3553-3561.
46. Kuo C.N., Yang L.C., Wu P.C., Kuo H.K., Kuo C.J., Tai M.H. Dehydrated form of plasmid expressing basic fibroblast growth factor-polyethylenimine complex is a novel and accurate method for gene transfer to the cornea. Curr Eye Res 2005, 30:1015-1024.
47. Sunshine J.C., Sunshine S.B., Bhutto I., Handa J.T., Green J.J. Poly(beta-amino ester)-nanoparticle mediated transfection of retinal pigment epithelial cells invitro and invivo. PLoS One 2012, 7:e37543.
48. Peng C.H., Cherng J.Y., Chiou G.Y., Chen Y.C., Chien C.H., Kao C.L., et al. Delivery of Oct4 and SirT1 with cationic polyurethanes-short branch PEI to aged retinal pigment epithelium. Biomaterials 2011, 32:9077-9088.
49. Muzzarelli R.A., Tubertini O. Chitin and chitosan as chromatographic supports and adsorbents for collection of metal ions from organic and aqueous solutions and sea-water. Talanta 1969, 16:1571-1577.
50. Kim Y.H., Gihm S.H., Park C.R., Lee K.Y., Kim T.W., Kwon I.C., et al. Structural characteristics of size-controlled self-aggregates of deoxycholic acid-modified chitosan and their application as a DNA delivery carrier. Bioconjug Chem 2001, 12:932-938.
51. Erbacher P., Zou S., Bettinger T., Steffan A.M., Remy J.S. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998, 15:1332-1339.
52. Liao Z.X., Peng S.F., Ho Y.C., Mi F.L., Maiti B., Sung H.W. Mechanistic study of transfection of chitosan/DNA complexes coated by anionic poly(gamma-glutamic acid). Biomaterials 2012, 33:3306-3315.
53. Mehmet Saka O., Bozkir A. Formulation and invitro characterization of PEGylated chitosan and polyethylene imine polymers with thrombospondin-I gene bearing pDNA. JBiomed Mater Res B Appl Biomater 2012, 100:984-992.
54. Shi B., Shen Z., Zhang H., Bi J., Dai S. Exploring N-imidazolyl-O-carboxymethyl chitosan for high performance gene delivery. Biomacromolecules 2012, 13:146-153.
55. Zhou H., Yang L., Li H., Gong H., Cheng L., Zheng H., et al. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells. Int J Nanomedicine 2012, 7:4649-4660.
56. Prow T.W., Bhutto I., Kim S.Y., Grebe R., Merges C., McLeod D.S., et al. Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 2008, 4:340-349.
57. Klausner E.A., Zhang Z., Wong S.P., Chapman R.L., Volin M.V., Harbottle R.P. Corneal gene delivery: chitosan oligomer as a carrier of CpG rich, CpG free, or S/MAR plasmid DNA. JGene Med 2011, 14:100-108.
58. Jin J., Zhou K.K., Park K., Hu Y., Xu X., Zheng Z., et al. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor. Invest Ophthalmol Vis Sci 2011, 52:6230-6237.
59. Mohammadi Z., Dorkoosh F.A., Hosseinkhani S., Gilani K., Amini T., Najafabadi A.R., et al. Invivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung. Int J Pharm 2011, 421:183-188.
60. Jayaraman M.S., Bharali D.J., Sudha T., Mousa S.A. Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration. Mol Vis 2012, 18:2300-2308.
61. Lai J.Y., Li Y.T., Wang T.P. Invitro response of retinal pigment epithelial cells exposed to chitosan materials prepared with different cross-linkers. Int J Mol Sci 2010, 11:5256-5272.
62. Liu G., Li D., Pasumarthy M.K., Kowalczyk T.H., Gedeon C.R., Hyatt S.L., et al. Nanoparticles of compacted DNA transfect postmitotic cells. JBiol Chem 2003, 278:32578-32586.
63. Ziady A.G., Gedeon C.R., Miller T., Quan W., Payne J.M., Hyatt S.L., et al. Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles invivo. Mol Ther 2003, 8:936-947.
64. Davis P.B., Cooper M.J. Vectors for airway gene delivery. AAPS J 2007, 9:E11-E17.
65. Koirala A., Makkia R.S., Cooper M.J., Naash M.I. Nanoparticle-mediated gene transfer specific to retinal pigment epithelial cells. Biomaterials 2011, 32:9483-9493.
66. Fink T.L., Klepcyk P.J., Oette S.M., Gedeon C.R., Hyatt S.L., Kowalczyk T.H., et al. Plasmid size up to 20 kbp does not limit effective invivo lung gene transfer using compacted DNA nanoparticles. Gene Ther 2006, 13:1048-1051.
67. Han Z., Conley S.M., Makkia R.S., Cooper M.J., Naash M.I. DNA nanoparticle-mediated ABCA4 delivery rescues Stargardt dystrophy in mice. JClin Invest 2012, 122:3221-3226.
68. Chen X., Kube D.M., Cooper M.J., Davis P.B. Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. Mol Ther 2008, 16:333-342.
69. Chen X., Shank S., Davis P.B., Ziady A.G. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Mol Ther 2011, 19:93-102.
70. Boylan N.J., Kim A.J., Suk J.S., Adstamongkonkul P., Simons B.W., Lai S.K., et al. Enhancement of airway gene transfer by DNA nanoparticles using a pH-responsive block copolymer of polyethylene glycol and poly-l-lysine. Biomaterials 2012, 33:2361-2371.
71. Ding X.Q., Quiambao A.B., Fitzgerald J.B., Cooper M.J., Conley S.M., Naash M.I. Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina. PLoS ONE 2009, 4:e7410.
72. Yurek D.M., Flectcher A.M., Kowalczyk T.H., Padegimas L., Cooper M.J. Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons. Cell Transplant 2009, 18:1183-1196.
73. Konstan M.W., Davis P.B., Wagener J.S., Hilliard K.A., Stern R.C., Milgram L.J., et al. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther 2004, 15:1255-1269.
74. Fletcher A.M., Kowalczyk T.H., Padegimas L., Cooper M.J., Yurek D.M. Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor. Neuroscience 2011, 194:220-226.
75. Cai X., Nash Z., Conley S.M., Fliesler S.J., Cooper M.J., Naash M.I. Apartial structural and functional rescue of a retinitis pigmentosa model with compacted DNA nanoparticles. PLoS One 2009, 4:e5290.
76. Farjo R., Skaggs J., Quiambao A.B., Cooper M.J., Naash M.I. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One 2006, 1:e38.
77. Cai X., Conley S.M., Nash Z., Fliesler S.J., Cooper M.J., Naash M.I. Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa. FASEB J 2010, 24:1178-1191.
78. Han Z., Conley S.M., Makkia R., Guo J., Cooper M.J., Naash M.I. Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One 2012, 7:e52189.
79. Koirala A., Makkia R.S., Conley S.M., Cooper M.J., Naash M.I. S/MAR-containing DNA nanoparticles promote persistent RPE gene expression and improvement in RPE65-associated LCA. Hum Mol Genet 2013, 22:1632-1642.
80. Han Z., Koirala A., Makkia R., Cooper M.J., Naash M.I. Direct gene transfer with compacted DNA nanoparticles in retinal pigment epithelial cells: expression, repeat delivery and lack of toxicity. Nanomedicine (Lond) 2012, 7:521-539.
81. de Queiroz J.M., Blanks J.C., Ozler S.A., Alfaro D.V., Liggett P.E. Subretinal perfluorocarbon liquids. An experimental study. Retina 1992, 12:S33-S39.
82. Lederberg J. Cell genetics and hereditary symbiosis. Physiol Rev 1952, 32:403-430.
83. Riethoven J.J. Regulatory regions in DNA: promoters, enhancers, silencers, and insulators. Methods Mol Biol 2010, 674:33-42.
84. Magnusson T., Haase R., Schleef M., Wagner E., Ogris M. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations. JGene Med 2011, 13:382-391.
85. Kay M.A., Li Q., Liu T.J., Leland F., Toman C., Finegold M., et al. Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery invivo. Hum Gene Ther 1992, 3:641-647.
86. Kuriyama S., Yoshikawa M., Ishizaka S., Tsujii T., Ikenaka K., Kagawa T., et al. Apotential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector. Cell Struct Funct 1991, 16:503-510.
87. Spilianakis C.G., Lalioti M.D., Town T., Lee G.R., Flavell R.A. Interchromosomal associations between alternatively expressed loci. Nature 2005, 435:637-645.
88. Luke J.M., Vincent J.M., Du S.X., Gerdemann U., Leen A.M., Whalen R.G., et al. Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers. Gene Ther 2011, 18:334-343.
89. Appleby C.E., Kingston P.A., David A., Gerdes C.A., Umana P., Castro M.G., et al. Anovel combination of promoter and enhancers increases transgene expression in vascular smooth muscle cells invitro and coronary arteries invivo after adenovirus-mediated gene transfer. Gene Ther 2003, 10:1616-1622.
90. Nicoud M., Kong J., Iqball S., Kan O., Naylor S., Gouras P., et al. Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors. JGene Med 2007, 9:1015-1023.
91. Cross D.S., Burmester J.K. Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines. Med Oncol 2008, 25:40-49.
92. Corbo J.C. The role of cis-regulatory elements in the design of gene therapy vectors for inherited blindness. Expert Opin Biol Ther 2008, 8:599-608.
93. West A.G., Gaszner M., Felsenfeld G. Insulators: many functions, many mechanisms. Genes Dev 2002, 16:271-288.
94. Burgess-Beusse B., Farrell C., Gaszner M., Litt M., Mutskov V., Recillas-Targa F., et al. The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci U S A 2002, 99(Suppl.4):16433-16437.
95. Li C.L., Xiong D., Stamatoyannopoulos G., Emery D.W. Genomic and functional assays demonstrate reduced gammaretroviral vector genotoxicity associated with use of the cHS4 chromatin insulator. Mol Ther 2009, 17:716-724.
96. Nielsen T.T., Jakobsson J., Rosenqvist N., Lundberg C. Incorporating double copies of a chromatin insulator into lentiviral vectors results in less viral integrants. BMC Biotechnol 2009, 9:13.
97. Sharma N., Hollensen A.K., Bak R.O., Staunstrup N.H., Schroder L.D., Mikkelsen J.G. The impact of cHS4 insulators on DNA transposon vector mobilization and silencing in retinal pigment epithelium cells. PLoS One 2012, 7:e48421.
98. Miccio A., Poletti V., Tiboni F., Rossi C., Antonelli A., Mavilio F., et al. The GATA1-HS2 enhancer allows persistent and position-independent expression of a beta-globin transgene. PLoS One 2011, 6:e27955.
99. Chung J.H., Bell A.C., Felsenfeld G. Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci U S A 1997, 94:575-580.
100. Emery D.W., Yannaki E., Tubb J., Stamatoyannopoulos G. Achromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci U S A 2000, 97:9150-9155.
101. Gallagher P.G., Steiner L.A., Liem R.I., Owen A.N., Cline A.P., Seidel N.E., et al. Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis. JClin Invest 2010, 120:4453-4465.
102. Ben-Hattar J., Jiricny J. Methylation of single CpG dinucleotides within a promoter element of the Herpes simplex virus tk gene reduces its transcription invivo. Gene 1988, 65:219-227.
103. Chen Z.Y., Riu E., He C.Y., Xu H., Kay M.A. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther 2008, 16:548-556.
104. Jabbari K., Bernardi G. Cytosine methylation and CpG, TpG (CpA) and TpA frequencies. Gene 2004, 333:143-149.
105. Ramirez-Ortiz Z.G., Specht C.A., Wang J.P., Lee C.K., Bartholomeu D.C., Gazzinelli R.T., et al. Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun 2008, 76:2123-2129.
106. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
107. Martino A.T., Suzuki M., Markusic D.M., Zolotukhin I., Ryals R.C., Moghimi B., et al. The genome of self-complementary adeno-associated viral vectors increases toll-like receptor 9-dependent innate immune responses in the liver. Blood 2011, 117:6459-6468.
108. Klinman D.M., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A 1996, 93:2879-2883.
109. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. JImmunol 1996, 157:1840-1845.
110. Yew N.S., Zhao H., Przybylska M., Wu I.H., Tousignant J.D., Scheule R.K., et al. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression invivo. Mol Ther 2002, 5:731-738.
111. Darquet A.M., Cameron B., Wils P., Scherman D., Crouzet J. Anew DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther 1997, 4:1341-1349.
112. Riu E., Chen Z.Y., Xu H., He C.Y., Kay M.A. Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression invivo. Mol Ther 2007, 15:1348-1355.
113. Darquet A.M., Rangara R., Kreiss P., Schwartz B., Naimi S., Delaere P., et al. Minicircle: an improved DNA molecule for invitro and invivo gene transfer. Gene Ther 1999, 6:209-218.
114. Osborn M.J., McElmurry R.T., Lees C.J., DeFeo A.P., Chen Z.Y., Kay M.A., et al. Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of alpha-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther 2011, 19:450-460.
115. Argyros O., Wong S.P., Fedonidis C., Tolmachov O., Waddington S.N., Howe S.J., et al. Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver. JMol Med (Berl) 2011, 89:515-529.
116. Hirata K., Nishikawa M., Kobayashi N., Takahashi Y., Takakura Y. Design of PCR-amplified DNA fragments for invivo gene delivery: size-dependency on stability and transgene expression. JPharm Sci 2007, 96:2251-2261.
117. Nakai H., Montini E., Fuess S., Storm T.A., Meuse L., Finegold M., et al. Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice. Mol Ther 2003, 7:101-111.
118. Chen Z.Y., Yant S.R., He C.Y., Meuse L., Shen S., Kay M.A. Linear DNAs concatemerize invivo and result in sustained transgene expression in mouse liver. Mol Ther 2001, 3:403-410.
119. Johansson P., Lindgren T., Lundstrom M., Holmstrom A., Elgh F., Bucht G. PCR-generated linear DNA fragments utilized as a hantavirus DNA vaccine. Vaccine 2002, 20:3379-3388.
120. Schakowski F., Gorschluter M., Junghans C., Schroff M., Buttgereit P., Ziske C., et al. Anovel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA. Mol Ther 2001, 3:793-800.
121. Fukunaga S., Kanda G., Tanase J., Harashima H., Ohyama T., Kamiya H. Adesigned curved DNA sequence remarkably enhances transgene expression from plasmid DNA in mouse liver. Gene Ther 2012, 19:828-835.
122. Sumida N., Nishikawa J., Kishi H., Amano M., Furuya T., Sonobe H., et al. Adesigned curved DNA segment that is a remarkable activator of eukaryotic transcription. FEBS J 2006, 273:5691-5702.
123. Kawamoto T., Makino K., Orita S., Nakata A., Kakunaga T. DNA bending and binding factors of the human beta-actin promoter. Nucleic Acids Res 1989, 17:523-537.
124. Bode J., Goetze S., Heng H., Krawetz S.A., Benham C. From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics. Chromosome Res 2003, 11:435-445.
125. Benham C., Kohwi-Shigematsu T., Bode J. Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions. JMol Biol 1997, 274:181-196.
126. Martens J.H., Verlaan M., Kalkhoven E., Dorsman J.C., Zantema A. Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes. Mol Cell Biol 2002, 22:2598-2606.
127. Jenke B.H., Fetzer C.P., Stehle I.M., Jonsson F., Fackelmayer F.O., Conradt H., et al. An episomally replicating vector binds to the nuclear matrix protein SAF-A invivo. EMBO Rep 2002, 3:349-354.
128. Dickinson L.A., Dickinson C.D., Kohwi-Shigematsu T. An atypical homeodomain in SATB1 promotes specific recognition of the key structural element in a matrix attachment region. JBiol Chem 1997, 272:11463-11470.
129. Jackson D.A., Juranek S., Lipps H.J. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol Ther 2006, 14:613-626.
130. Goetze S., Gluch A., Benham C., Bode J. Computational and invitro analysis of destabilized DNA regions in the interferon gene cluster: potential of predicting functional gene domains. Biochemistry (Mosc) 2003, 42:154-166.
131. Bode J., Benham C., Knopp A., Mielke C. Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit Rev Eukaryot Gene Expr 2000, 10:73-90.
132. Stehle I.M., Scinteie M.F., Baiker A., Jenke A.C., Lipps H.J. Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication. Chromosome Res 2003, 11:413-421.
133. Goetze S., Baer A., Winkelmann S., Nehlsen K., Seibler J., Maass K., et al. Performance of genomic bordering elements at predefined genomic loci. Mol Cell Biol 2005, 25:2260-2272.
134. Gasser S.M., Laemmli U.K. Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster. Cell 1986, 46:521-530.
135. Kellum R., Schedl P. Agroup of scs elements function as domain boundaries in an enhancer-blocking assay. Mol Cell Biol 1992, 12:2424-2431.
136. Jenuwein T., Forrester W.C., Fernandez-Herrero L.A., Laible G., Dull M., Grosschedl R. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 1997, 385:269-272.
137. Wong S.P., Argyros O., Coutelle C., Harbottle R.P. Non-viral S/MAR vectors replicate episomally invivo when provided with a selective advantage. Gene Ther 2011, 18:82-87.
138. Argyros O., Wong S.P., Niceta M., Waddington S.N., Howe S.J., Coutelle C., et al. Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector. Gene Ther 2008, 15:1593-1605.
139. Papapetrou E.P., Ziros P.G., Micheva I.D., Zoumbos N.C., Athanassiadou A. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element. Gene Ther 2006, 13:40-51.
140. Bainbridge J.W., Smith A.J., Barker S.S., Robbie S., Henderson R., Balaggan K., et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. NEngl J Med 2008, 358:2231-2239.
141. Cideciyan A.V., Aleman T.S., Boye S.L., Schwartz S.B., Kaushal S., Roman A.J., et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Natl Acad Sci U S A 2008, 105:15112-15117.
142. Maguire A.M., Simonelli F., Pierce E.A., Pugh E.N., Mingozzi F., Bennicelli J., et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. NEngl J Med 2008, 358:2240-2248.
143. Pitkanen L., Pelkonen J., Ruponen M., Ronkko S., Urtti A. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an invitro bovine eye model. AAPS J 2004, 6:e25.
144. Machado-Aranda D.A., Suresh M., Yu B., Raghavendran K. Electroporation-mediated invivo gene delivery of the Na+/K+-ATPase pump reduced lung injury in a mouse model of lung contusion. JTrauma 2012, 72:32-40.
145. Potter H., Heller R. Transfection by electroporation. Curr Protoc Neurosci 2011, Appendix 1:1E.
146. Zolochevska O., Figueiredo M.L. Advances in sonoporation strategies for cancer. Front Biosci (Schol Ed) 2012, 4:988-1006.
147. Davtyan H., Ghochikyan A., Movsesyan N., Ellefsen B., Petrushina I., Cribbs D.H., et al. Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses. Neurodegener Dis 2012, 10:261-264.
148. Morgan J.L., Kerschensteiner D. Shooting DNA, dyes, or indicators into tissue slices using the gene gun. Cold Spring Harb Protoc 2011, 2011:1512-1514.
149. Keating A., Toneguzzo F. Gene transfer by electroporation: a model for gene therapy. Prog Clin Biol Res 1990, 333:491-498.
150. Touchard E., Berdugo M., Bigey P., El Sanharawi M., Savoldelli M., Naud M.C., et al. Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina. Mol Ther 2012, 20:1559-1570.
151. Liaw J., Chang S.F., Hsiao F.C. Invivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles. Gene Ther 2001, 8:999-1004.
152. Spencer B., Agarwala S., Miskulin M., Smith M., Brandt C.R. Herpes simplex virus-mediated gene delivery to the rodent visual system. Invest Ophthalmol Vis Sci 2000, 41:1392-1401.